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Abstract
The coronavirus disease 2019 (COVID-19) has quickly grown from a regional outbreak in
Wuhan, China to a global pandemic. Early estimates of the epidemic growth and incubation
period of COVID-19 may have been biased due to sample selection. Using detailed case reports
from 14 locations in and outside mainland China, we obtained 378 Wuhan-exported cases who left
Wuhan before an abrupt travel quarantine. We developed a generative model we call BETS for
four key epidemiological events—Beginning of exposure, End of exposure, time of Transmission,
and time of Symptom onset (BETS)—and derived explicit formulas to correct for the sample
selection. We gave a detailed illustration of why some early and highly influential analyses of the
COVID-19 pandemic were severely biased. All our analyses, regardless of which subsample and
model were being used, point to an epidemic doubling time of 2 to 2.5 days during the early
outbreak in Wuhan. A Bayesian nonparametric analysis further suggests that about 5% of the
symptomatic cases may not develop symptoms within 14 days of infection and that men may be
much more likely than women to develop symptoms within 2 days of infection.
∗Correspondence to: Dr. Qingyuan Zhao, Centre for Mathematical Sciences, Wilberforce Road, Cambridge, CB3
0WB, United Kingdom. Email:qyzhao@statslab.cam.ac.uk.
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1 Introduction
On December 31, 2019, the Health Commission in Wuhan, China, announced 27 cases of unknown
viral pneumonia and alerted the World Health Organization. The causative pathogen was quickly
identified as a novel coronavirus and the disease was later designated as the coronavirus disease 2019
(COVID-19) [4]. The regional outbreak in Wuhan quickly turned into a global pandemic. As of
April 15, 2020, COVID-19 has reached almost every country in the world, infected at least 2 million
people, and killed at least 130,000 [2].
Researchers around the world quickly responded to the COVID-19 outbreak. In particular, many
have examined early outbreak data to estimate the initial epidemic growth, using COVID-19 cases
confirmed in Wuhan or elsewhere. Two early studies published in premier medical journals by the
end of January estimated that the epidemic doubling time in Wuhan was about 6 to 7 days [17, 28],
but other studies appearing around the same time found that the doubling time was drastically
shorter, about 2 to 3 days [23, 25, 29]. How the pandemic subsequently developed around the
world seems to suggest that the latter estimates were much closer to truth. By simply plotting the
cumulative cases and deaths over time, it is evident now that the number of cases (and deaths) grew
more than 100 times 20 days after the first 100 cases (and 10 deaths) in countries most heavily hit
by the pandemic such as Italy, Spain, and the United States (Figure 1). That growth rate almost
exactly corresponds to a doubling time of 3 days. Nevertheless, to our knowledge there is no formal
explanation for this drastic difference, and it might have caused confusion during the early phase of
containment of COVID-19. For example, during the UK government’s daily briefing on March 16, it
was acknowledged that “without drastic action, cases could double every five or six days” [3]. Less
than two weeks later, that number was revised to “three to four days” [1].
For infectious diseases, another key epidemiological parameter is the incubation period. Several
studies have attempted to estimate the incubation period distribution of COVID-19 using cases
exported from Wuhan [5, 15, 18] and the results have been influential in shaping guidelines to manage
confirmed COVID-19 patients. For example, the interim clinical guidance for managing COVID-19
patients published by the Centers for Disease Control and Prevention (CDC) [6] quoted the results
of Lauer et al. [15] that “97.5% of persons with COVID-19 who develop symptoms will do so within
11.5 days of SARS-CoV-2 infection.” However, as we will demonstrate below in Section 4, the design
and statistical inference of these studies are highly susceptible to selection bias.
In general, there are several potential sources of bias in early analyses of the COVID-19 pandemic
(see also Table 1):
(i) Under-ascertainment: Because COVID-19 is a new disease, the testing capacity was very
limited during the early stage of the outbreak. The eligibility criterion for testing was initially
very strict. This may explain why Li et al. [17] under-estimated the epidemic growth as they
only used cases in Wuhan who showed symptoms before January 5, 2020.
(ii) Non-random sample selection: Not all public health agencies reported detailed information
of COVID-19 cases. Many stopped doing so after the first few cases. Studies which only collect
complete or conveniently available data may be biased by non-random sample selection. For
example, it is often impossible to know the exact time when the cases were infected. If one
simply uses cases with known infection time, the incubation period may be under-estimated
because it is more difficult to discern the infection time for cases with longer incubation period.
(iii) Travel quarantine: Wuhan is a major transportation hub in central China. To control the
spread of the virus, all outbound travels from Wuhan were abruptly halted on January 23,
2020. For studies using cases exported from Wuhan (COVID-19 cases who were infected in
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Figure 1: Growth of the COVID-19 pandemic around the world (data retrieved from https:
//www.worldometers.info/ on April 15, 2020).
Wuhan and confirmed elsewhere), ignoring the sample selection due to the travel quarantine
leads to biased estimates of the epidemic growth.
(iv) Ignoring epidemic growth: Because the epidemic was rapidly growing, patients were more
likely to be infected towards the end of their exposure period. Ignoring the growth and using a
simple uniform distribution for the infection time over a prolonged exposure period may lead
to over-estimation of the incubation period.
(v) Right-truncation: Early analyses of the epidemic were limited to using cases confirmed
before a certain date, when the number of infections was still growing rapidly. This may
lead to under-estimation of the incubation period, as people with milder symptoms or longer
incubation period are less likely to be included in the study.
In this article, we address these challenges by carefully constructing a study sample and a
statistical model. We collected key epidemiological information for 1,460 confirmed COVID-19 cases
across 14 locations in and outside mainland China. By focusing on locations where the local health
agencies made great efforts to contain the initial outbreaks and published detailed case reports,
the biases due to (i) under-ascertainment and (ii) non-random selection are minimized. Section 2
describes how our data were collected and the Wuhan-exported cases were discerned.
We addressed potential biases due to (iii) the travel quarantine, (iv) ignoring epidemic growth,
and (v) right-truncation by constructing a generative statistical model. We call it the BETS model,
as it models four key epidemiological events: Beginning of exposure, End of exposure, time of
Transmission, and time of Symptom onset. The travel quarantine puts a constraint on the support
of the observed data for Wuhan-exported cases, for which we carefully worked out the selection
probability and used it to adjust the likelihood function. Epidemic growth is naturally considered
in the estimation of the incubation period because they are estimated jointly using the likelihood
3
Bias Susceptible studies Direction Solutions
(i) Under-ascertainment: Symp-
tomatic patients did not seek health-
care or could not be diagnosed.
All studies using cases
confirmed when testing is
insufficient.
Varied, depending on
the pattern of under-
ascertainment and param-
eter of interest.
Use carefully considered and planned
study designs.
(ii) Non-random sample selection:
Cases included in the study are not
representative of the population.
All studies, as detailed in-
formation of COVID-19
cases is sparse, but espe-
cially those without clear
inclusion criteria.
Varied. Follow a protocol for data collection
and exclude data that do not meet the
sample inclusion criterion.
(iii) Travel quarantine: Outbound
travel from Wuhan was banned from
January 23, 2020 to April 8, 2020.
Studies that analyze cases
exported from Wuhan.
Under-estimation of
epidemic growth [28] and
infection-to-recovery time
[8].
Derive tailored likelihood functions to
account for travel restrictions. (See
Section 4.1.)
(iv) Epidemic growth: Patients
were more likely to be infected towards
the end of their exposure period.
Studies that treat infec-
tions as uniformly dis-
tributed over the exposure
period.
Over-estimation of in-
cubation period [5, 15, 18]
and serial interval [9, 22].
Derive tailored likelihood functions to
account for epidemic growth. (See Sec-
tion 4.2.)
(v) Right-truncation: Cases con-
firmed after a certain time are excluded
from the dataset.
Studies that only use
cases detected early in an
epidemic.
Under-estimation of in-
cubation period [5, 15, 18],
serial interval [9, 22], and
disease severity.
1. Collect all cases that meet a selec-
tion criterion, do not end data collec-
tion prematurely; 2. Derive tailored
likelihood functions to correct for right-
truncation. (See Section 4.2.)
Table 1: Summary of potential biases in analyses of the COVID-19 pandemic.
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functions we derived. Sample selection due to right-truncation can also be characterized and adjusted
for. Details of the generative model and likelihood inference can be found in Section 3.
We then give a detailed explanation in Section 4 of why some early analyses of the COVID-19
outbreak were severely biased, including the estimation of epidemic growth by Wu et al. [28] and
the estimation of incubation period by Backer et al. [5], Lauer et al. [15], Linton et al. [18]. Because
these analyses did not start from a generative model, they could not correctly adjust for sample
selection in their statistical inference.
In order to obtain closed-form likelihood functions in Section 3, we introduced some parametric
assumptions which necessarily restrict the shape of the tail of the incubation period distribution. To
avoid biased tail estimates, we model the distribution nonparametrically and also relax the other
assumptions in Section 5. Because the likelihood function is no longer available in closed form,
a Markov Chain Monte Carlo (MCMC) sampler is needed for Bayesian nonparametric inference.
Finally, we summarize our findings and discuss potential limitations of our study in Section 6. All
technical derivations can be found in the appendix; our dataset and statistical programs are publicly
available as an R package from https://github.com/qingyuanzhao/bets.covid19.
2 Data
2.1 Data Collection
We identified 14 locations where the local health agencies have published continuous reports for every
confirmed COVID-19 case since the first local case. Out of the 14 locations, 8 are cities/provinces in
mainland China: Hefei, Guilin, Jinan, Shaanxi, Shenzhen, Yangzhou, Xinyang, Zhanjiang and 6 are
countries/regions in East Asia: Hong Kong, Japan, South Korea, Macau, Singapore, and Taiwan
(Figure 2). These locations have varied levels of economic development and patterns of traveling
to/from Wuhan. Key information (close contact, travel history, symptom onset) of the confirmed
COVID-19 cases was collected based on press releases of the official health agencies (Table 2). In
total, there are 1,460 COVID-19 cases in the collected dataset.
For the mainland Chinese locations, the dataset included all the cases confirmed as of February 29,
2020. In Chinese cities outside the Hubei province, local epidemics were considered to be successfully
contained by the end of February. For the international locations, the dataset included all the cases
confirmed before February 15, more than three weeks after the outbound travel quarantine of Wuhan
on January 23. It is thus safe to say that our dataset contains almost all Wuhan-exported cases
confirmed in these locations.
2.2 Discerning Wuhan-exported cases
We define Wuhan-exported cases as those who were infected in Wuhan and confirmed elsewhere.
In total, 614 cases in our dataset are potentially exported from Wuhan because they had stayed in
Wuhan before got diagnosed elsewhere. Because Wuhan was the first center of epidemic outbreak
and traveling from/to Wuhan was not restricted before January 23, it is reasonable to assume that
most of these 614 cases were infected there. However, some uncertainty arises if a case had contact
with other confirmed cases outside their stay in Wuhan, in one of the following scenarios:
• The case already had contact with other confirmed cases before their stay in Wuhan (4 cases);
• The case had contact with other confirmed cases only after they left Wuhan but before they
arrived at their destination, for example in trains or flights (4 cases);
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Column name Description Example1 Summary statistics
Case Unique identifier for each case HongKong-05 1460 in total
Residence Nationality or residence of the case Wuhan 21.5% reside in Wuhan
Gender Gender Male /Female 52.1%/47.7% (0.2% unknown)
Age Age 63 Mean=45.6, IQR=[34, 57]
Known Contact Have known epidemiological contact2? Yes /No 84.7%/15.3%
Cluster Relationship with other cases Husband of 32.1% known
HongKong-04
Outside Transmitted outside Wuhan?3 Yes/ Likely /No 58.5%/7.7%/33.8%
Begin Wuhan Begin of stay in Wuhan (B) 30-Nov4
End Wuhan End of stay in Wuhan (E) 22-Jan
Exposure Period of exposure 1-Dec to 22-Jan 58.9% known period/date
8.2% known date
Arrived Final arrival date at the location 22-Jan 40.6% did not travel outside
where confirmed a COVID-19 case
Symptom Date of symptom onset (S) 23-Jan 9.0% unknown
Initial Date of first medical visit/quarantine 23-Jan 6.5% unknown
Confirmed Date confirmed as a COVID-19 case 24-Jan
Table 2: A summary of the key columns in the collected dataset. Boxed entries correspond to the
recorded values of the example (HongKong-05).
1Description of this case in Hong Kong government’s press release on January 24, 2020: “The other two cases
are a married couple of residents of in Wuhan, a 62-year-old female [HongKong-04] and a 63-year-old male
[HongKong-05], with good prior health conditions. Based on information provided by the patients, They
took a high-speed train departing from Wuhan at 2:20pm, January 22, and arrived at the West Kowloon
station around 8pm. The female patient had a fever since yesterday with no respiratory symptoms. The male
patient started to cough yesterday and had a fever today. They went to the emergency department at the
Prince of Wales Hospital yesterday and were admitted to the hospital for treatment in isolation. Currently
their health conditions are stable. Respiratory samples of the two patients were tested positive for the novel
coronavirus.” (translated from Chinese).
2A case is considered to have known epidemiological contact if he/she had contact with people from the
Hubei province or had contact with another case confirmed earlier.
3See the main text for the criterion we used to classify the cases.
4The beginning of stay is treated as November 30 if the case resides in Wuhan and has no known beginning
of stay.
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Figure 2: Geographical locations of the confirmed cases in our dataset.
• The case had close contact with other confirmed cases (usually family members who traveled
together from Wuhan) after they reached their travel destination (131 cases).
To discern a dataset of Wuhan-exported cases, the principle we followed is to exclude cases if
there is a “reasonable doubt” that they could be infected outside Wuhan. We assumed in the first
two scenarios above, the cases were transmitted outside Wuhan. For the third scenario, it is likely
that the cases were transmitted outside Wuhan, but at least one of the cases in each cluster were
transmitted in Wuhan. (Two cases are considered to belong two the same cluster if they are in the
family or had other recorded contact.) We used a column called Outside in our dataset to record
our best judgment on whether the cases were transmitted outside Wuhan using the following rules:
(i) Outside = “Yes”: Cases with no recorded stay in Wuhan between December 1, 2019 and
January 23, 2020, and the 8 cases in the first two scenarios above (854 cases).
(ii) Outside = “Likely”: Wuhan-exposed cases who did not show symptoms during the recorded
stay in Wuhan and had recorded contact with another confirmed COVID-19 case with an
earlier symptom onset (112 cases).
(iii) Outside = “No”: Wuhan-exposed cases who had no recorded contact with other confirmed
7
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Figure 3: Epidemic curves in different locations stratified by whether the cases were transmitted
outside Wuhan. “China - Other” includes four Chinese cities: Guilin, Jinan, Yangzhou, Zhanjiang;
“International” includes six Asian countries/regions: Hong Kong, Japan, Korea, Macau, Singapore,
Taiwan. The dashed vertical lines correspond to the abrupt travel quarantine of Wuhan from January
23, 2020.
cases, or had the earliest symptom onset in their cluster or showed symptoms during their stay
in Wuhan (494 cases).
Figure 3 shows the local epidemic curves stratified by the Outside column in different locations.
The dataset we collected has relatively few missing values in the key entries needed for epidemic
modeling. Among the Outside = “No” cases, only 6.5% do not have the exact date they left Wuhan
and only 8.1% have missing symptom onset date (including those showing no symptoms at the
time of confirmation). We imputed the missing end of exposure to Wuhan by the day of the travel
quarantine (January 23) and excluded the cases with missing symptom onset. This left us with
458 cases. We further excluded cases who arrived at the location where they are diagnosed with
COVID-19 after January 23 as they have a different traveling pattern than the other cases. In the
end we obtained 378 cases who were exported from Wuhan.
3 Statistical model and parametric inference
3.1 BETS: A generative model
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On a high level, our goal is to make inference about the epidemic in Wuhan using its “shadows”
observed in other locations. To properly consider the consequences of sample selection, we will
first outline a generative model for (which is also named after) four key epidemiological events:
the beginning of stay in Wuhan B, the end of stay in Wuhan E, the usually unobserved time of
transmission T , and the time of symptom onset S (BETS). These four variables are well defined
regardless of whether the person has been to Wuhan, contracted the pathogenic coronavirus, or
showed symptoms of COVID-19.
Study population: Exposed to Wuhan
Consider the population of all people who stayed in Wuhan any time between 12AM December 1,
2019 (time 0) and 12AM January 24, 2020 (time L when outbound travel from Wuhan was banned,
L = 54) in local time. We introduce the following conventions to define the population with exposure
to Wuhan:
• B = 0: The person started their stay in Wuhan before December 2019.
• E = ∞: The person did not arrive in the 14 locations we are considering before the travel
quarantine (time L). For the purpose of this study, we need not differentiate between people
who stayed in Wuhan or went to a location different from the ones we are considering.
• T =∞: The person did not contract the pathogenic virus during their stay in Wuhan. For
the purpose of this study, we need not differentiate between people who contracted the virus
outside their Wuhan stay and people who never contracted the virus.
• S =∞: The person did not show symptoms of COVID-19, either because they never contracted
the virus or they were asymptomatic.
Because we are only considering people exposed to Wuhan, we have B ≤ L. Two other natural
constraints are B ≤ E and T ≤ S (where we allow ∞ ≤∞). Therefore, the support of (B,E, T, S)
for the Wuhan-exposed population is
P =
{
(b, e, t, s) | b ∈ [0, L], e ∈ [b, L] ∪ {∞}, t ∈ [b, e] ∪ {∞}, s ∈ [t,∞]
}
. (1)
Notice that although B is supported on [0, L], B = 0 is a point mass representing Wuhan
residents and is categorically different from B =  for some small positive . All density functions of
B below are defined with respect to the sum of Lebesgue measure on the real line and degenerate
counting measure for {0}. Similarly, for E, T , and S the dominating measure is the sum of Lebesgue
measure and the counting measure for {∞}. Joint densities of (B,E, T, S) below are defined with
respect to their product measure.
Full data BETS model: Independence of traveling and disease transmission/progression
In Section 3.2 below we will define the constraints corresponding to our sample selection. But first,
we will introduce a generative statistical model for (B,E, T, S) in the whole study population P.
The joint density of (B,E, T, S) can always be factorized as:
f(b, e, t, s) = fB(b) · fE(e | b) · fT (t | b, e) · fS(s | b, e, t). (2)
Throughout this article we will maintain two general assumptions about two conditional densities
in this factorization:
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Figure 4: Directed acyclic graph (DAG) for the BETS model. B is the beginning of exposure, E is
the end of exposure, T is the time of transmission, and S is the time of symptom onset.
Assumption 1. The conditional density fT (t | b, e) does not depend on b and e in the range
b ≤ t ≤ e, so it can be written as
fT (t | b, e) =
{
g(t), if b < t < e,
1− ∫ eb g(x) dx, if t =∞. (3)
Here g(t) ≥ 0 models the epidemic growth in Wuhan before the citywide quarantine on January
23; it can be interpreted as the instantaneous probability of being infected in Wuhan at time t and
satisfies the constraint
∫ L
0 g(x) dx ≤ 1.
Assumption 2. The conditional density fS(s | b, e, t) does not depend on b and e, so it can be
written as
fS(s | b, e, t) =
{
ν · h(s− t), if s <∞,
1− ν, if s =∞. (4)
Here h(s− t) is the conditional density of the incubation period S − T given that S − T <∞ (the
case is not asymptomatic), so h(·) satisfies ∫∞0 h(x) dx = 1.
Assumptions 1 and 2 essentially mean that the disease transmission and progression are indepen-
dent of traveling, which allows us to extend conclusions learned from the Wuhan-exported sample to
the whole population. Assumption 2 is equivalent to the conditional independence S ⊥ (B,E) | T ,
which can be represented as a directed acyclic graphical (DAG) model (Figure 4) on the distribution
of (B,E, T, S) [16]. Assumption 1 further restricts the dependence of T on (B,E). Under these
two assumptions, the BETS model is then parameterized by two kinds of parameters: the nuisance
parameters for the traveling pattern fB(·) and fE(· | ·), and the parameters of interest for disease
transmission g(·) and progression h(·).
Like any other assumptions in epidemic models, Assumptions 1 and 2 represent approximations
to the underlying dynamics. Assumptions 1 and 2 can be violated if, for example, short-term
visitors were exposed to more infectious cases or if people were less likely to travel if they felt sick.
Nevertheless, we think they are reasonable approximations to the reality during the initial outbreak,
when little was known about the new infectious disease.
Parametric assumptions for closed-form likelihood functions
Assumptions 1 and 2 are general assumptions on the dependence of T and S on B and E. We
consider two parametric assumptions that simplify the interpretation of our results:
Assumption 3. The probability of contracting the virus in Wuhan was increasing exponentially
before the quarantine:
g(t) = gκ,r(t)
∆
= κ · exp(rt), t ≤ L, (5)
where (κ, r) satisfies
∫ L
0 gκ,r(t) dt ≤ 1.
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Assumption 4. The incubation period T − S, given that it is finite (the case is not asymptomatic),
follows a Gamma distribution with shape α > 0 and rate β > 0:
h(s− t) = hα,β(s− t) ∆= β
α
Γ(α)
(s− t)α−1 exp{−β(s− t)}. (6)
Assumption 3 says that the epidemic size in Wuhan was growing exponentially before the
quarantine, which is a common assumption for early epidemic outbreaks. We think it is quite
reasonable given that little was known about the novel coronavirus before January 23. Assumption 4
restricts the density function h(·) to the Gamma family, which is commonly used to model the
distribution of the incubation period. These two assumptions will be used later in this and the next
sections to calculate closed-form likelihood functions. Later in Section 5, we will relax the parametric
assumptions to allow more flexible patterns for the epidemic growth and more general distributions
of the incubation period.
3.2 Accounting for sample selection in the likelihood
Study sample: Wuhan-exported cases
To use Wuhan-exported cases to study the epidemic growth and incubation period, it is crucial
to consider the effect of sample selection on Wuhan-exported cases. Using the notation above,
the Wuhan-exported cases confirmed in the 14 locations we consider can be written as an event
(B,E, T, S) ∈ D where
D = {(b, e, t, s) ∈ P | b ≤ t ≤ e ≤ L, t ≤ s <∞}. (7)
Compared to the full population P of people with exposure to Wuhan in (1), the set D makes three
further restrictions:
(i) B ≤ T ≤ E, because we only use cases who contracted the virus during their stay in Wuhan;
(ii) E ≤ L, because the case can only be observed in the dataset if they left Wuhan before the
travel quarantine;
(iii) S < ∞, because not all locations report asymptomatic cases, which motivates us to only
consider COVID-19 cases who showed symptoms.
Selection-adjusted likelihood functions
In an ideal world where we could take independent observations (Bi, Ei, Ti, Si), i = 1, . . . , n from
the exposed population P, the likelihood function would be given by a product of the density
f(Bi, Ei, Ti, Si) in (2) over i. However, that is almost impossible for the initial COVID-19 outbreak
in Wuhan. Because of limited testing capacity in the beginning of the outbreak, many COVID-19
patients in Wuhan were not identified.
Instead, in Section 2 we have obtained a high-quality dataset of Wuhan-exported cases which
can be considered as “shadows” of the epidemic in Wuhan. To use this dataset, it is crucial that the
statistical inference takes into account the sample selection because we do not have independent
observations from P . Instead, we may view our sample as independent observations generated from
the following density:
f(b, e, t, s | D) ∆= f(b, e, t, s | (B,E, T, S) ∈ D) = f(b, e, t, s) · 1{(b,e,t,s)∈D}
P
(
(B,E, T, S) ∈ D) , (8)
11
where 1{·} is the indicator function. To reduce cluttering, we will omit the indicator 1{(b,e,t,s)∈D} if it
is clear from the context that we are considering sample from the Wuhan-exported cases D. We can
then use the product
n∏
i=1
f
(
Bi, Ei, Ti, Si | D
)
, (9)
as the likelihood function, under the assumption that we have observed an independent and identically
distributed sample (Bi, Ei, Ti, Si), i = 1, . . . , n from the density (8).
A further difficulty is that the time of transmission T is usually unobserved in our dataset. To
solve this problem, we can either treat T as a latent variable and maximize the likelihood over
both the modeling parameters and the unobserved Ti, or simply marginalize over T in the full data
likelihood and use the following observed data likelihood,
Luncond(θ) =
n∏
i=1
∫
f
(
Bi, Ei, t, Si | D
)
dt, (10)
where θ = (fB(·), fE(· | ·), g(·), h(·)) contains all the parameters of interest.
We can also condition on (B,E) to formulate a conditional likelihood function that does not
depend on the marginal distribution of (B,E):
Lcond(θ) =
n∏
i=1
∫
fT,S
(
t, Si | Bi, Ei,D
)
dt, (11)
where θ = (g(·), h(·)) and
fT,S(t, s | b, e,D) ∆= fT,S
(
t, s | B = b, E = e, (B,E, T, S) ∈ D) = fT,S(t, s | b, e)
P((B,E, T, S) ∈ D | B = b, E = e) .
(12)
The information about the epidemic growth g(·) and the incubation period h(·) contained in the
density fB,E(b, e | D) is not used in the conditional likelihood, but the benefit is that it does not
require us to specify the nuisance parameters fB(·) and fE(· | ·) to model the traveling. In other
words, the conditional likelihood is less efficient than the unconditional likelihood but more robust.
Next we derive the likelihood functions (10) and (11). For the unconditional likelihood function
we will make additional parametric modeling assumptions on the traveling pattern fB(·) and fE(· | ·).
Computing the selection probability
The first technical problem is to compute the denominators in (8) and (12). This is straightforward
for the conditional likelihood:
Lemma 1. Under Assumptions 1 and 2, for (b, e, t, s) ∈ D,
P((B,E, T, S) ∈ D | B = b, E = e) = ν[G(e)−G(b)], and fT,S(t, s | b, e,D) = g(t)h(s− t)
G(e)−G(b) . (13)
where G(t) =
∫ t
−∞ g(x) dx. If we additionally assume g(t) is growing exponentially (Assumption 3),
we have
fT,S(t, s | b, e,D) =

r exp(rt)
exp(re)− exp(rb) h(s− t), for r 6= 0,
1
e− b h(s− t), for r = 0.
(14)
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An important observation here is that (14) does not depend on ν (proportion of symptomatic
cases) and κ (absolute scale of the epidemic). Conditional likelihood Lcond(θ) can then be derived
by integrating (14) over t and the precise formula can be found in Proposition 1 below.
For the denominator in the unconditional likelihood, we need to integrate P((B,E, T, S) ∈ D |
B = b, E = e) in Lemma 1 over the marginal distribution of B and E. We make the following
simplifying assumptions on fB(b) and fE(e | b) which heuristically say that the travel pattern is
stable during the study period:
Assumption 5. The beginning of stay in Wuhan B, conditioning on 0 < B ≤ L, follows a uniform
distribution from 0 to L. More specifically,
fB(b) =
{
1− pi, for b = 0,
pi/L, for 0 < b ≤ L, (15)
where 0 ≤ pi ≤ 1 is the proportion of visitors (non-residents of Wuhan) in the Wuhan-exposed
population.
Assumption 6. The end of stay E follows an uniform distribution from B to L given E ≤ L, with
rate depending on whether the person resides in Wuhan:
fE(e | b = 0) =
{
λW , if 0 ≤ e ≤ L,
1− LλW , if e =∞,
, fE(e | b, b > 0) =
{
λV , if b ≤ e ≤ L,
1− (L− b)λV , if e =∞,
(16)
where the parameters λW , λV ≤ 1/L.
For b > 0, Assumption 6 implies that P(E = ∞ | b, b > 0) = bλV + (1 − LλV ) increases as b
increases. This is consistent with our intuition that the later someone arrives in Wuhan, the more
likely that person stays there after the travel quarantine on January 23.
By using the parametric forms (5), (15), (16) when integrating P((B,E, T, S) ∈ D | B = b, E = e)
and using the approximation (1 + rL)/ exp(rL) ≈ 0 for rL > 5, we obtain the following result.
Lemma 2. Under Assumptions 1 to 3, 5 and 6, for r > 5/L, the selection probability is given by
P((B,E, T, S) ∈ D) ≈ κ exp(rL)ν
r2
[
(1− pi)λW + piλV
(
1− 2
rL
)]
,
and for (b, e, t, s) ∈ D, the density in (8) is given by
f(b, e, t, s | D) ≈ r2 · [1{b=0} + (ρ/L)1{b>0}] · exp(rt)[
1 + ρ(1− 2/(rL))
]
· exp(rL)
· h(s− t), (17)
where 1{·} is the indicator function and ρ = (λV /λW ) · pi/(1− pi).
Similar to (14), the conditional density (17) does not depend on ν and κ. Moreover, it only
depends on the traveling parameters pi, λV and λW through a single transformed parameter ρ. The
approximation (1 + rL)/ exp(rL) ≈ 0 we used in the Appendix to obtain the analytical formulae in
Lemma 2 is quite reasonable for rL > 5 (if the doubling time is 4 days, rL = log(2)/4× 54 = 9.34).
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Observed data likelihood
As explained after equation (9), we cannot immediately use the densities in (14) and (17) for
statistical inference because we do not observe the time of transmission T . The final step in the
derivation of our likelihood function is to marginalize over t in the density functions. The parametric
form of h(·) in Assumption 4 allows us to derive closed-form formulae.
Proposition 1. Under Assumptions 1 to 4, the observed data conditional likelihood (11) is given by
Lcond(r, α, β) =

rn
( β
β + r
)nα · n∏
i=1
exp(rSi)
[
Hα,β+r(Si −Bi)−Hα,β+r((Si − Ei)+)
]
exp(rEi)− exp(rBi) , for r > 0,
n∏
i=1
Hα,β(Si −Bi)−Hα,β((Si − Ei)+)
Ei −Bi , for r = 0,
(18)
where Hα,β(·) is the cumulative distribution function of the Gamma distribution with shape α and
rate β and (x)+ = max(x, 0) is the positive part of x. Under Assumptions 1 to 6, the observed data
unconditional likelihood (10) for r > 5/L is approximately given by
Luncond(ρ, r, α, β) ≈ r2n
( β
β + r
)nα · n∏
i=1
{
1{Bi=0} + (ρ/L)1{Bi>0}
1 + ρ(1− 2/(rL)) exp
{
r(Si − L)
}
× [Hα,β+r(Si −Bi)−Hα,β+r((Si − Ei)+)]}. (19)
It is worthwhile to point out that if r = 0 (the epidemic was stationary), our conditional
likelihood function Lcond(r, α, β) reduces to the likelihood function for interval-censored exposure
in Reich et al. [24]. However, COVID-19 was growing quickly during its early outbreak in Wuhan,
so the growth exponent r is very different from 0. It is thus inappropriate to use the likelihood
Lcond(0, α, β) to estimate the incubation period of COVID-19, as done in some previous analyses
also using Wuhan-exported cases [5, 15, 18]. See Section 4.2 for further discussion and an illustration
of the bias due to ignoring the epidemic growth.
3.3 Results of the parametric inference
Implementation
To fit the statistical model, we used the 378 Wuhan-exported cases that satisfy our sample selection
criterion and do not have missing symptom onset date. We fitted separate models for different
locations to compare the results across the locations.
As the model in Section 3 is a regular parametric model, we performed the usual frequentist
inference using the likelihood function (19). In particular, point estimators of the parameters
(ρ, r, α, β) were obtained by maximizing the likelihood function (19), and confidence intervals for the
parameters were obtained by inverting the likelihood ratio χ2-test. As we are more interested in
quantiles of the incubation period instead of the shape and rate parameters, we parametrized the
Gamma distribution in Assumption 4 by its median and 95% quantile and mapped them to α and β
when calculating the likelihood function. The growth exponent r was also transformed to the more
interpretable doubling time (in days) using doubling time = log(2)/r.
Because we only observed the date instead of the exact time for B, E, and S, we applied a simple
transformation before computing the likelihood function. Instead of using the integer date which
corresponds to the end of a day, we used B − 3/4, E − 1/4, and S − 1/2 in places of B, E, and S
14
Location
Sample
ρ
Doubling time Incubation period
size (in days) Median 95% quantile
Conditional likelihood
China - Hefei 34 Not estimated 2.1 (1.2–3.7) 4.3 (2.9–6.0) 12.0 (9.1–17.3)
China - Shaanxi 53 Not estimated 1.7 (1.0–2.8) 4.5 (3.1–6.2) 14.6 (11.5–19.8)
China - Shenzhen 129 Not estimated 2.2 (1.7–3.0) 3.5 (2.8–4.3) 11.2 (9.5–13.6)
China - Xinyang 74 Not estimated 2.3 (1.5–3.5) 6.8 (5.4–8.2) 16.4 (13.8–20.1)
China - Other 42 Not estimated 2.0 (1.1–3.4) 5.1 (3.6–6.7) 12.3 (9.8–16.4)
International 46 Not estimated 2.1 (1.4–3.4) 3.8 (2.5–5.3) 10.9 (8.4–15.1)
All locations 378 Not estimated 2.1 (1.8–2.5) 4.5 (4.0–5.0) 13.4 (12.2–14.8)
All except Xinyang 304 Not estimated 2.1 (1.7–2.5) 4.0 (3.5–4.6) 12.2 (11.0–13.7)
Unconditional likelihood
China - Hefei 34 0.40 (0.18–0.82) 1.8 (1.4–2.4) 4.1 (2.8– 5.5) 11.9 (9.0–17.2)
China - Shaanxi 53 0.24 (0.11–0.46) 2.5 (2.0–3.1) 5.3 (3.9– 6.8) 15.0 (12.0–20.0)
China - Shenzhen 129 0.75 (0.52–1.06) 2.4 (2.1–2.8) 3.6 (2.9– 4.3) 11.3 (9.6–13.7)
China - Xinyang 74 0.45 (0.27–0.74) 2.4 (2.0–2.9) 6.8 (5.6– 8.1) 16.4 (13.9–20.2)
China - Other 42 0.45 (0.22–0.86) 2.1 (1.7–2.8) 5.3 (4.0– 6.6) 12.4 (10.0–16.4)
International 46 0.14 (0.05–0.32) 2.0 (1.6–2.6) 3.7 (2.5– 5.0) 10.8 (8.4–15.1)
All locations 378 0.45 (0.36–0.56) 2.3 (2.1–2.5) 4.6 (4.1– 5.1) 13.5 (12.3–14.9)
All except Xinyang 304 0.45 (0.35–0.57) 2.2 (2.1–2.5) 4.1 (3.7– 4.6) 12.3 (11.1–13.8)
Table 3: Results of the parametric inference. For each location and parameter, the maximum
likelihood estimator and the 95% confidence interval (in brackets) based on inverting the likelihood
ratio test are reported.
to compute (18) and (19). This transformation also avoids a singularity in the likelihood function
when B and E are exactly equal.
Results
Results of the parametric model in Section 3 are reported in Table 3. We give some remarks about
the results:
(i) There is considerable heterogeneity of the estimated ρ (a parameter capturing the traveling
pattern) using the unconditional likelihood. This is not surprising given that the locations we
are considering are different in many ways.
(ii) Regardless of the location, our model shows that the epidemic doubling time in Wuhan was
less than 3 days. There is no substantial heterogeneity among estimates in different locations.
(iii) The estimated incubation periods are similar for most locations except Xinyang, a less developed
city neighboring the Hubei province.
(iv) The conditional likelihood (18) and unconditional likelihood (19) give very similar results.
Confidence intervals for the doubling time computed using the unconditional likelihood are
slightly shorter than those computed using the conditional likelihood.
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In conclusion, inferences based on our parametric model suggest that the initial doubling time
of the COVID-19 epidemic in Wuhan was between 2 to 2.5 days, the median incubation period of
COVID-19 is around 4 days, and the 95% quantile of the incubation period is between 11 to 15 days.
4 Why some previous COVID-19 analyses were severely biased
4.1 Estimating the epidemic growth: Bias due to ignoring the travel quarantine
In this section we discuss the selection bias in some early COVID-19 analyses. Like the present study,
a highly influential article published in the Lancet in late January also used Wuhan-exported cases
to estimate the epidemic growth during the early outbreak [28]. However, their estimated doubling
time was 6.4 days (95% credible interval: 5.8–7.1), drastically higher than the estimates in Table 3.
A closer look at the model in Wu et al. [28] shows that the most likely reason is that their model
did not consider how sample selection (in particular, the travel quarantine of Wuhan) changes the
likelihood function. This issue is best illustrated by examining the marginal distribution of symptom
onset in Wuhan-exported cases, which can be obtained by integrating the conditional density (17)
obtained earlier. In the Proposition below we focus on the exported cases who are Wuhan residents
(B = 0), whose marginal distributions of T and S are slightly cleaner than those who visited Wuhan
(B > 0).
Proposition 2. Under Assumptions 1 to 3, 5 and 6, the marginal density of T given (B,E, T, S) ∈ D
for r > 5/L is approximately given by
fT (t | D, B = 0) ∝∼ exp(rt)(L− t) · 1{t≤L}, (20)
where ∝∼ means approximately proportional to. If in addition the incubation period S − T follows a
Gamma(α, β) distribution (Assumption 4) and L > 4(α+ 5)/(β + r), the marginal density of S of
the exported cases is approximately given by, for s ≥ L/2,
fS(s | D, B = 0) ∝∼ exp(rs) ·
{
(L−s)[1−Hα,β+r((s−L)+)]+ α
β + r
[1−Hα+1,β+r((s−L)+)]
}
, (21)
As a consequence,
fS(s | D, B = 0) ∝∼ exp(rs) ·
(
L+
α
β + r
− s
)
for L/2 ≤s ≤ L. (22)
The technical assumption L > 4(α+ 5)/(β+ r) is used to control the tail probability of a Gamma
distribution so we may replace Hα,β+r(s) and Hα+1,β+r(s) by 1 in (21). It is usually satisfied if L is
larger than several times the mean incubation period α/β and is satisfied here with the maximum
likelihood estimator of (r, α, β) in Section 3.3.
Figure 5 shows the histogram of the symptom onset of the exported cases in our dataset who
are Wuhan residents (B = 0) and the theoretical fit based on (21) and the maximum unconditional
likelihood estimator in Table 3 using all the locations (r = 0.30, α = 1.86, β = 0.33). The theoretical
density provided good fit to the observed distribution of S (Pearson’s χ2 goodness-of-fit test: p-value
= 0.94).
Wu et al. [28] fitted a Susceptible-Exposed-Infectious-Recovered (SEIR) model using Wuhan-
exported cases but did not consider sample selection due to the travel quarantine. In the early phase
of epidemic outbreaks, the SEIR model can be well approximated by an exponential growth for cases
in Wuhan:
fS(s) ∝∼ exp(rs).
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Figure 5: Marginal distribution of symptom onset of exported COVID-19 cases who are Wuhan
residents. Histogram: Density of the symptom onset date of the cases dataset; Orange curve:
Theoretical fit based on (21); Blue dashed line: Date of travel quarantine for Wuhan (January 23,
2020).
However, Proposition 2, in particular equation (22), shows that the marginal distribution of S for
exported Wuhan residents fS(s | D, B = 0) does not follow the same exponential growth as fS(s).
Equation (22) not only shows that fitting a simple exponential growth to the initial symptom
onsets among Wuhan-exported cases will under-estimate the epidemic growth r, it can also be used
to derive a simple bias-correction formula. We can approximate the log-linear regression for symptom
incidence counts from L− c to L by a first-order Taylor expansion at the midpoint:
log fS(s | D, B = 0) ≈ rs+ log
(
L+
α
β + r
− s
)
+ constant
= rs+ log
(
α/(β + r) + c/2 + (L− c/2− s)
)
+ constant
≈ rs+ log
( α
β + r
+
c
2
)
+
L− c/2− s
α/(β + r) + c/2
+ constant
=
[
r − 1
α/(β + r) + c/2
]
s+ constant.
Therefore the under-estimation bias is about (α/(β + r) + c/2)−1. As most of the symptom onsets
of Wuhan-exported cases before the travel quarantine happened within two weeks, it might be
reasonable to choose c = 14. Using our estimate of (r, α, β) in Table 3, the under-estimation bias is
about ((1.86)/(0.3 + 0.33) + 14/2)−1 ≈ 0.1.
Using Wuhan-exported cases confirmed outside Mainland China by January 28, 2020, Wu et al.
[28] estimated that the doubling time of COVID-19 was about 6.4 days, which corresponds to
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r = log(2)/6.2 ≈ 0.11. With the above correction, the estimated r would be 0.11 + 0.1 ≈ 0.21, or
doubling time of 3.3 days. In other words, this simple correction already shows that the epidemic
could be doubling twice as fast as estimated by Wu et al. [28].
The actual bias of the analysis in Wu et al. [28] is more complicated than the inexact calculations
above. This is because Wu et al. [28] fitted their SEIR model also using symptom onset after January
23 (time L). Our theory in Proposition 2 suggests that the fS(s | D) not only has slower and slower
growth as s approaches L but also decreases eventually. This means that the inclusion of symptom
onsets after January 23 may lead to further under-estimation of r. This also explains why, after the
simple correction above, the epidemic growth estimate of Wu et al. [28] is still not as fast as ours in
Table 3.
4.2 Estimating the incubation period: When two biases do not “balance out”
Like the present study, several influential articles also estimated the incubation period of COVID-19
using Wuhan-exported cases [5, 15, 18]. Their results are roughly in line with our estimates in
Table 3 with lighter tails, but a closer look shows that the existing methods actually suffer from two
biases:
(i) Bias due to right-truncation: The three previous studies only used Wuhan-exported cases
confirmed before the end of January. In our dataset, about 70% of the Wuhan-exported cases
were confirmed by that time. However, the other 30% would have an incubation period of at
least 8 days as they must have left Wuhan before January 23. The right truncation, if not
accounted for, leads to under-estimation of the incubation period.
(ii) Bias due to ignoring epidemic growth: The three previous studies all used the interval-
censored likelihood function for the incubation period in Reich et al. [24]. As discussed after
Proposition 1, this likelihood corresponds to our conditional likelihood Lcond(α, β) with r fixed
at 0 and thus does not account for the rapid growth of COVID-19. Intuitively, a person in
Wuhan has a much higher prior probability of contracting the virus on January 20 than on
January 1, but the likelihood function in Reich et al. [24] does not take that into account.
Ignoring the epidemic growth leads to over-estimation of the incubation period.
It is possible to correct for the right-truncation by further conditioning on S ≤M (M is some
truncation time) in our likelihood function.
Proposition 3. Under Assumptions 1 and 2, for (b, e, t, s) ∈ D and s ≤M ,
fT,S(t, s | b, e,D, S ≤M) = g(t)h(s− t)∫ max(e,s)
b g(t)H(M − t) dt
, (23)
where H(s) =
∫ s
0 h(x) dx is the distribution function of the incubation period. Furthermore, under the
exponential growth model (Assumption 3) and Gamma-distributed incubation period (Assumption 4),
the conditional observed data likelihood under the right truncation S ≤M is given by
Lcond,trunc(r, α, β;M)
=

rn
( β
β + r
)nα n∏
i=1
exp{r(Si −M)}[Hα,β+r(Si −Bi)−Hα,β+r((Si − Ei)+)]
Zr(M −Bi)− Zr((M − Ei)+) , if r 6= 0,
n∏
i=1
Hα,β(Si −Bi)−Hα,β((Si − Ei)+)
Z0(M −Bi)− Z0((M − Ei)+) , if r = 0,
(24)
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where
Zr(x) =

( β
β + r
)α
Hα,β+r(x)− exp(−rx)Hα,β(x), if r 6= 0,
xHα,β(x)−
(α
β
)
Hα+1,β(x), if r = 0.
It is straightforward to show that Lcond,trunc(r, α, β;M) reduces to the conditional likelihood
Lcond(r, α, β) without the right truncation in (18) when M →∞.
We demonstrate the two kinds of biases in the estimation of the incubation period using a
retrospective experiment. In this experiment, we assumed the incubation period follows a Gamma
distribution and estimated its median and the 95% quantile by maximizing one of the following
three likelihood functions:
(i) Adjusted for nothing: This is the likelihood function in Reich et al. [24] that is equal to
our Lcond(0, α, β) by setting r = 0.
(ii) Adjusted for growth: This is our conditional likelihood function Lcond(r, α, β).
(iii) Adjusted for both growth and right-truncation: This is our conditional likelihood
Lcond,trunc(r, α, β;M) with adjustment for sample selection due to the right-truncation S ≤M .
For each day from January 23 to February 18, we estimated the incubation distribution using
Wuhan-exported cases in our dataset confirmed by that day. For the third method, we choose M
to be a week prior to the truncation date for confirmation, as most Wuhan-exported cases were
confirmed within a week of symptom onset. Figure 6 shows the estimated medians and 95% quantiles
of the incubation period of COVID-19, with pointwise confidence intervals in the plot computed
using the basic nonparametric bootstrap with 1000 resamples [10].
The bias due to not accounting for right-truncation can be clearly visualized from the dotted
blue curves in Figure 6. Had we fitted our conditional likelihood function Lcond(r, α, β) using cases
confirmed by January 31 (265 cases), the estimated median incubation period would be 3.5 days and
the 95% quantile would be 9.5 days. In comparison, when the entire dataset is used, the estimated
median and 95% quantile are 4.6 days and 13.5 days (Table 3).
The over-estimation due to ignoring the epidemic growth is even more dramatic. Had we fitted
the incubation period using the likelihood function in Reich et al. [24] (the same as setting r = 0
in our conditional likelihood) to all the cases in our dataset (387 cases), the estimated median
incubation period would be 9.2 days and the 95% quantile would be a whopping 24.9 days!
The truncation-corrected conditional likelihood Lcond,trunc(r, α, β;M) derived in Proposition 3
successfully corrected for the right-truncation bias. The estimated median and 95% quantile of the
incubation using Lcond,trunc(r, α, β;M) were roughly unbiased starting from the end of January. Had
we fitted this likelihood using all cases confirmed by January 31 and having shown symptoms a week
prior (220 cases), the estimated median incubation period would be 4.8 days (95% CI: 3.0 to 6.0)
and the estimated 95% quantile would be 14.4 days (95% CI: 6.7 to 18.5). These estimates are less
precise than the estimates obtained using the entire dataset (Table 3), but they correctly reflect the
uncertainty due to the right-truncation. In contrast, using the wrong likelihood functions not only
results in biased point estimates but also narrow and misleading confidence intervals.
Because the right-truncation bias and epidemic growth bias are towards opposite directions,
coincidentally they were almost “balanced out” in the previous studies. As a consequence, their
estimates were not drastically different from ours. To be fair in our criticism, the previous studies
did acknowledge that under-ascertainment of mild cases could bias their analyses. Backer et al. [5]
mentioned the over-estimation due to ignoring epidemic growth in their discussion. Linton et al. [18]
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Figure 6: An illustration of two kinds of biases in the estimation of the incubation period of
COVID-19. The curves (region) in the plot are maximum likelihood estimators (and bootstrap
confidence intervals) using three likelihood functions and cases confirmed by each day. Likelihood
functions used in this experiment are: Lcond(0, α, β) (dashed orange), Lcond(r, α, β) (dotted blue),
and Lcond,trunc(r, α, β;M) (solid green). Results of some previous studies [5, 15, 18] (essentially using
our conditional likelihood with r set to 0 on different datasets) are also shown in this plot.
(Lauer et al. [15] did not report an estimated 95% quantile of the incubation period. Here we
imputed it based on the reported median and 97.5% quantile, assuming a Gamma distribution for
the incubation period. Although Lauer et al. [15] used COVID-19 cases confirmed as late as late
February, only 4 out of their 181 cases were confirmed in February. In this Figure it is thus treated
as using cases confirmed up till February 1.)
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attempted to use a formula to correct for right-truncation which bears some similarity to (23), which
resulted in slightly longer estimates of the incubation period. However, Linton et al. [18] did not
give any justification to the formula and we could not derive it from our generative model. In any
case, our experiments in Figure 6 clearly show that these early estimates of the incubation period
(especially their tail estimates) are unreliable to guide health policies.
5 Nonparametric inference
5.1 Time discretization
So far we have used parametric assumptions (e.g. Gamma-distributed incubation period) to explicitly
derive likelihood functions for the observed data. To assess the robustness of our results, we next
relax some of these parametric assumptions. In particular, we will model the distribution of the
incubation period nonparametrically so the tail probabilities are not determined by any parametric
form. Because analytic forms of the sample selection probabilities P((b, e, t, s) ∈ D | b, e) and
P((b, e, t, s) ∈ D) are generally unavailable, we will put prior distributions on the model parameters
and use Markov Chain Monte Carlo (MCMC) to compute their posterior distributions.
We start by discretizing all the time variables in the model, which are measured in days. This
will simplify the Bayesian computation. Instead of working with continuous time (B,E, T, S) ∈ P,
we use the discretization:
B∗ = dBe, E∗ = dEe, T ∗ = dT e, S∗ = dSe,
where d·e is the ceiling function (dxe is the smallest integer larger than x). The support of
(B∗, E∗, T ∗, S∗) is then P, the set of all 4-tuples of integers and ∞. The general continuous
distributions in Assumptions 1 and 2 can be modified accordingly:
P(T ∗ = t∗ | B∗ = b∗, E∗ = e∗) =
{
g∗(t∗), if b∗ ≤ t∗ ≤ e∗,
1−∑e∗t∗=b∗ g∗(t∗), if t∗ =∞;
P(S∗ = s∗ | B∗ = b∗, E∗ = e∗, T ∗ = t∗) =
{
ν · h∗(s∗ − t∗), if t∗ ≤ s∗ <∞,
1− ν, if s∗ =∞,
where g∗(·) satisfies ∑Lx∗=0 g∗(x∗) ≤ 1 and h∗(·) is a probability mass function on nonnegative
integers:
∑∞
x∗=0 h
∗(x∗) = 1.
5.2 Relaxing the parametric assumptions
Our parametric assumptions (Assumptions 3 to 6) on the distribution of (B,E, T, S) can be translated
to the following assumptions on (B∗, E∗, T ∗, S∗) after discretization:
g∗(t∗) ≈ gκ,r(t∗) = κ exp(rt∗), h∗(t∗ − s∗) ≈ hα,β(t∗ − s∗),
P(B∗ = b∗) =
{
(1− pi), for b∗ = 0,
pi/L, for b∗ = 1, . . . , L,
and
P(E∗ = e∗ | B∗ = b∗) =
{
λb∗ , for b∗ ≤ e∗ ≤ L,
1− (L− b∗ + 1)λb∗ , for e∗ =∞.
where λ0 = λW and λ1 = · · · = λL = λV .
In the nonparametric model we consider the following relaxations:
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(i) Nonparametric distribution for the incubation period: Besides putting a prior to
encourage smoothness and log-concavity, we do not put any parametric restrictions on the
distribution of the incubation period.
(ii) Two-stage exponential growth: Human-to-human transmissibility of COVID-19 is first
confirmed to the public in the evening of January 20. We modify the exponential growth model
to allow for a different growth exponent after January 20:
g∗(t∗) = g∗κ,r1,r2(t
∗) =
{
κ exp(r1t
∗) if t ≤ L1,
κ exp(r2(t
∗ − L1) + r∗1L1) if L1 < t ≤ L2,
where L1 = 51 (January 20) and L2 = L = 54 (January 23). The simple exponential growth
model is a special case of this model with both L1 and L2 set to L.
(iii) Geometric distribution for E∗ | B∗: As a sensitivity analysis to our assumption that
E∗ | B∗ is uniformly distributed between B∗ and L, this relaxation assumes a geometric
distribution for E∗ | B∗:
P(E∗ = e∗ | E∗ ≥ e∗, B∗) =
{
ηB∗,1 if e∗ < Lchunyun,
ηB∗,2 if e∗ ≥ Lchunyun,
where Lchunyun = 41 corresponds to January 10, the start of the Chinese New Year travel
season known as “chunyun”. We assume η0,i = ηW,i and η1,i = · · · = ηL,i = ηV,i, for i = 1, 2.
(iv) Gender-specific and age-specific incubation periods: To assess whether the distribution
of incubation period varies with gender, we use different densities, h∗M (·) for men and h∗F (·)
for women. Like in (i), we put no parametric restrictions on these distributions apart from
the same prior that encourages smoothness and log-concavity. Similarly, we can use different
densities for different age groups. To avoid fitting incubation period with too few observations,
we only consider two age groups: above 50 years old and below 50 years old. Notice that the
same exponential growth model for g is used for different gender or age groups, as we expect
the growth of the chance of infection is the same for all strata.
Under these different modeling assumptions, likelihood functions for the parameters can be
computed in the same way as in Section 3.2, with integrals replaced by finite sums. We omit the
details here.
5.3 Prior distributions and details of the implementation
To simplify the computation, we assume the incubation period of COVID-19 is less than 30 days. It
is common to use a unimodal distribution with a smooth density function to model the incubation
period. We use the following prior distribution on h∗(·) to encourage smoothness and log-concavity:
pi
(
h∗(0), . . . , h∗(29)
) ∝( 29∏
x∗=0
h∗(x∗)µ·h0(x
∗)−1
)
× exp
{ 28∑
x∗=1
(
2 log h∗(x∗)− log h∗(x∗ − 1)− log h∗(x∗ + 1))−}.
(25)
where (·)− is the negative part function. The first part of the right hand side of (25) is proportional
to the density of a Dirichlet distribution with concentration parameters {µ · h0(0), . . . , µ · h0(29)}.
22
We choose h0(·) to be a discretization of Gamma(9, 1.5), whose tail probability of ≥ 14 days is less
than 0.01. The second part of the right hand side of (25) is an exponential tilt which penalizes lack
of log-concavity.
We put uninformative priors on other parameters in the model:
r1 ∼ Exp(1), r2 ∼ N(0, 4), κ ∼ Unif(0, 1), λW , λV ∼ Unif(0, 1/L).
Note that r2 is allowed to be negative (exponential decrease after January 20). For the model with a
geometric distribution for E∗ | B∗, we put Unif(0, 1) priors on ηW,1, ηW,2, ηV,1, ηV,2.
A random walk Metropolis–Hastings algorithm targeting the posterior distribution of h∗(·) and
r1, r2 was implemented using the TensorFlow Probability library in Python [7]. We simulated chains
of 80, 000 steps, discarding a burn-in period of 50%. The convergence of the sampler was assessed
by simulating 8 parallel Markov chains with initial values overdispersed with respect to the target
distribution, and computing the potential of scale reduction factor [12] for r1, the mean of the
incubation period distribution, and the probability of an incubation period of 14 days or more. In
every case, the statistic was confidently below 1.1.
5.4 Results of Bayesian nonparametric inference
Aggregated results
Table 4 reports the results of the Bayesian nonparametric inference in 7 different scenarios. Overall,
they are not too dissimilar to the results of the parametric model in Table 3. Without restricting
the tail to follow that of a Gamma distribution, the estimated tail probabilities are slightly higher
than those in Table 3. The posterior mean for P(S∗ − T ∗ ≥ 14 days) exceeds 0.03 in all scenarios,
even when we exclude the cases confirmed in Xinyang who seemed to have longer incubation periods
in Table 3. Moreover, prior and posterior distributions of P(S∗ − T ∗ ≥ 14 days) show a large
discrepancy (Figure 7b), indicating that the posterior estimates of the tail probabilities are driven
by the data instead of the prior. Employing the two-stage epidemic growth model suggests that
the epidemic growth may have slowed down after January 20, but this more flexible model did not
alter the estimated doubling time and incubation period distribution substantially. Taken together,
our nonparametric models suggest that the probability of an incubation period of at least 14 days
(among symptomatic cases) may be about 5%.
Gender-specific and age-specific incubation periods
The gender-specific and age-specific estimates of the incubation period can be found in Table 5
and Figure 8a. The estimated distributions of incubation periods for men and women are notably
different, with the distribution of men peaking earlier and having a heavier tail than women. In
particular, men seem to be much more likely than women to develop symptoms within two days of
infection. A related phenomenon can be directly seen from the raw distribution of S −E (days from
leaving Wuhan to symptom onset; can be negative if a person showed symptoms during the stay in
Wuhan) for the cases exported from Wuhan (Figure 8b). The difference S − E appears to be more
spread out in men. A nonparametric Ansari-Bradley test for the dispersion gives a p-value ≈ 0.0025,
while the Wilcoxon signed-rank test for the location gives a p-value ≈ 0.48 [14].
The difference of incubation period distributions for older and younger cases seem less pronounced
in Figure 8a. Their distributions of S−E also appear to be quite similar in Figure 8b (Ansari-Bradley
test for dispersion: p-value ≈ 0.56; Wilcoxon test for location: p-value ≈ 0.1).
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scenarios of Table 4. Two panels corresponds to two choices for the prior distribution (25) of h∗(·).
Figure 7: An illustration of the nonparametric Bayesian fit to the incubation period distribution.
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(b) Gender-specific (left) and age-specific (right) distributions of S−E (days from leaving Wuhan to symptom
onset). Dots represent the exact proportions in the dataset and the curves are kernel density estimates with
bandwidth set to 1 day.
Figure 8: Results of the Bayesian nonparametric inference after stratification by gender and age.
Blue solid curves are for men and cases younger than 50 and orange dashed curves are for women
and cases older than 50.
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Sample All All Shenzhen Wuhan residents All except Xinyang All All
Growth r1 r1 r1 r1 r1 r1, r2 r1, r2
E∗ | B∗ Uniform Uniform Uniform Uniform Uniform Uniform Geometric
µ µ = 1 µ = 10 µ = 1 µ = 1 µ = 10 µ = 1 µ = 1
Doubling days for r1 2.4 (2.2–2.6) 2.4 (2.2–2.6) 2.5 (2.2–2.9) 2.3 (2.1–2.6) 2.4 (2.2–2.6) 2.2 (2.0–2.4) 2.2 (1.9–2.4)
r2 (Growth in Jan. 21–23) – – – – – .01 (-.23–.22) -.12 (-.40–.12)
Incubation
period
Mean 5.5 (5.0–5.9) 5.4 (5.0–5.9) 4.4 (3.7–5.1) 5.6 (5.0–6.1) 5.0 (4.6–5.5) 5.6 (5.1–6.1) 5.6 (5.2–6.1)
P(≥ 7) .31 (.25–.38) .31 (.25–.37) .22 (.13–.31) .30 (.22–.38) .26 (.19–.32) .05 (.02–.08) .06 (.03–.08)
P(≥ 10) .19 (.14–.24) .18 (.14–.22) .10 (.05–.17) .21 (.14–.28) .14 (.10–.19) .19 (.14–.23) .19 (.15–.24)
P(≥ 14) .05 (.02–.08) .04 (.02–.07) .03 (.01–.06) .04 (.01–.07) .03 (.01–.06) .05 (.02–.08) .06 (.03–.08)
P(≥ 21) .00 (.00–.01) .00 (.00–.00) .01 (.00–.03) .01 (.00–.02) .00 (.00–.01) .00 (.00–.01) .00 (.00–.01)
Table 4: Results of the nonparametric Bayesian inference where we do not impose a parametric form for the distribution of the incubation
period. As sensitivity analyses, we also vary the study sample, model for the epidemic growth, distribution of E∗ given B∗, and the
hyperprior parameter µ. Numbers reported in the table are posterior means and 95% credible intervals (in brackets).
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Subgroup Men Women Difference Age < 50 Age ≥ 50 Difference
Mean 5.8 (5.1–6.6) 5.3 (4.7–5.9) 0.5 (-0.4–1.5) 5.4 (4.7–6.1) 5.8 (5.2–6.5) -0.5 (-1.4–0.4)
P(≥ 2) .82 (.73–.92) .97 (.91–1.00) -.15 (-.25—.04) .90 (.78–.97) .89 (.81–.96) .01 (-.11–.13)
P(≥ 4) .59 (.50–.69) .55 (.42–.69) .04 (-.13–.20) .53 (.41–.65) .62 (.50–.72) -.09 (-.25–.07)
P(≥ 7) .37 (.29–.46) .24 (.17–.32) .13 (.01–.24) .31 (.22–.40) .34 (.26–.42) -.03 (-.14–.09)
P(≥ 10) .20 (.13–.28) .17 (.11–.23) .03 (-.06–.14) .20 (.13–.28) .18 (.13–.24) .01 (-.08–.11)
P(≥ 14) .07 (.04–.12) .03 (.01–.07) .04 (-.01–.09) .03 (.01–.07) .07 (.04–.11) -.03 (-.08–.01)
P(≥ 21) .01 (.00–.03) .00 (.00–.02) .00 (-.01–.02) .01 (.00–.03) .01 (.00–.01) .00 (-.01–.02)
Table 5: Estimated distributions of incubation period in different subgroups.
6 Discussion
In this article, we have proposed the generative BETS model for four key epidemiological events:
beginning of exposure, end of exposure, time of transmission, and time of symptom onset. Under
parametric models, we have derived the sample inclusion probability for exported cases and used it
to correct for selection bias in the likelihood functions. Across different sub-samples and modeling
assumptions, the initial epidemic doubling time for COVID-19 in Wuhan is consistently estimated
to be between 2 to 2.5 days. Our nonparametric Bayesian analysis suggests that the parametric fit
likely under-estimated the tail of the incubation period, and among all the COVID-19 patients who
develop symptoms, about 5% of them could develop the symptoms at least 14 days after contracting
the pathogenic virus. Gender-specific analysis shows that men may have a more variable incubation
period than women. In particular, more men appear to show symptoms within two days of infection,
which could be related to the men’s higher death rate across the world [13]. We hope the generality
of our model makes it extensible in further studies of the current pandemic and other outbreaks in
the future.
A key epidemiological parameter we decided not to study in this article is the basic reproduction
number, commonly denoted by R0. Intuitively, R0 is the expected number of secondary infections
produced by a typical case in a population where everyone is susceptible. In early outbreak analysis,
R0 can be estimated from the epidemic growth exponent r by R0 = 1/M(−r) [26], where M(·) is
the moment generating function for the distribution of the serial interval (time between successive
cases in a chain of transmission). Several studies have attempted to estimate the serial interval
of COVID-19 in Wuhan by using observed pairs of infector-infectees [17, 22, 9]. The reported
point estimate of the mean serial interval ranging from 4.0 [9] to 7.5 days [17]. However, for most
COVID-19 cases it seems impossible to ascertain the infector, so these early estimates of the serial
interval could be severely biased by sample selection just like the early estimates of epidemic growth
and incubation period as seen in Section 4.
Our findings in this article should be viewed together with the limitations of our methodology.
First of all, symptom onset time were usually reported by patients, who could be under social pressure
to report a later symptom onset (for example, so they did not travel when showing symptoms). This
can make estimated incubation longer than the truth. Second, although the contact tracing for
travelers from Wuhan was intensive in the locations included in our dataset, some degree of under-
ascertainment of Wuhan-exported cases is perhaps inevitable. If patients who showed symptoms
earlier were less likely to be ascertained, our analysis may have over-estimated the speed of the
epidemic growth. Third, the discernment of Wuhan-exported cases in Section 2.2 is not perfect;
for example, there is ambiguity about where some COVID-19 cases were infected if they both had
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stayed in Wuhan and were exposed to other confirmed cases after their stay. Another potential
limitation is the core assumptions that the disease transmission and progression are independent of
traveling. This assumption is necessary to extend the conclusions from a “shadow” of the epidemic
(Wuhan-exported cases) to the center of the outbreak, but it can be violated if, for example, some
people canceled travel plans due to feeling sick. Finally, it is possible that the population of travelers
is not representative of the general population in a meaningful way.
Nevertheless, these limitations are perhaps minor compared to the selection bias identified in this
article. Several authors have warned about selection bias and other statistical issues in COVID-19
studies [19, 20, 21, 11, 27]. By constructing a generative model and deriving the likelihood functions
from first principles, we gave a quantitative assessment of the selection bias in several high-impact
studies. We found that the biases were indeed startling. This highlights the lesson that data quality
and methodical consideration of selection bias are often much more important than data quantity and
specific models. This is especially important in high-stakes decisions like the ones for the COVID-19
pandemic. In a world where data science is playing an ever-larger role in policy making, ignoring
selection bias could become the most costly of bets.
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A Technical proofs
A.1 Derivation of Lemma 1
Using eqs. (3) and (4), it is straightforward to show that
P((B,E, T, S) ∈ D | B = b, E = e)
=P(b ≤ T ≤ e, T ≤ S <∞ | B = b, E = e)
=
∫
t∈(b,e)
fT (t | b, e)
∫
s∈(t,∞)
fS(s | b, e, t) ds dt
=
∫
t∈(b,e)
fT (t | b, e)
{∫
s∈(t,∞)
ν · h(s− t) ds
}
dt
=
∫
t∈(b,e)
fT (t | b, e) · ν dt
=ν[G(e)−G(b)].
A.2 Derivation of Lemma 2
By Assumption 3, Gκ,r(t) =
∫ t
−∞ gκ,r(s) ds = (κ/r) exp(rt). Thus for b > 0, we have
P((b, E, T, S) ∈ D | B = b)
=ν
∫
e∈(b,L)
fE(e | b)
[
Gκ,r(e)−Gκ,r(b)
]
de
=ν
∫ L
b
λV (κ/r) {exp(re)− exp(rb)} de
=
λV κν
r
[1
r
(
exp(rL)− exp(rb))− (L− b) exp(rb)]
=
λV κν
r2
exp(rL)− λV κν
r
(r−1 + L− b) exp(rb)
=
λV κν
r2
exp(rL)
[
1− (1 + r(L− b)) exp(−r(L− b))
]
.
(26)
For b = 0, we can replace λV in the above equation by λW .
The idea is that, if rL is much larger than 1 (in our preliminary analysis rL ≈ 0.25× 54 = 13.5),
then
Right hand side of (26) ≈ νλWκ
r2
exp(rL) when b = 0.
Using this approximation, we obtain
P((B,E, T, S) ∈ D)
=
∫
0≤b<L
P((b, E, T, S) ∈ D | B = b) fB(b) db
=P(B = 0) · P((b, E, T, S) ∈ D | B = 0) +
∫
0<b<L
P((b, E, T, S) ∈ D | B = b) fB(b) db
≈(1− pi)λWκν
r2
exp(rL) +
∫
0<b<L
P((b, E, T, S) ∈ D | B = b) fB(b) db
=
(1− pi)λWκν
r2
exp(rL) + pi
∫ L
0
1
L
λV κν
r2
exp(rL)
[
1− (1 + r(L− b)) exp(−r(L− b))
]
db
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=
(1− pi)λWκν
r2
exp(rL) +
piλV κν
r2
exp(rL)− pi
L
λV κν
r2
exp(rL)
∫ L
0
[
(1 + r(L− b)) exp(−r(L− b))
]
︸ ︷︷ ︸
A1
db
≈κ exp(rL)ν
r2
[
(1− pi)λW + piλV (1− 2/(rL))
]
.
In the last step we used the approximation erL  1 + rL:
A1 =
∫ L
0
(1 + rx) exp(−rx) dx = −exp(−rx)(rx+ 2)
r
∣∣∣x=L
x=0
=
2
r
− exp(−rL)(rL+ 2)
r
≈ 2
r
.
Therefore, the density is given by
f(b, e, t, s | D) ≈ [(1− pi)λW 1{b=0} + (pi/L)λV 1{b>0}] · κ exp(rt) · νh(s− t)
r−2κ exp(rL)ν
[
(1− pi)λW + piλV (1− 2/(rL))
]
=r2 · [(1− pi)λW 1{b=0} + (pi/L)λV 1{b>0}] · exp(rt)[
(1− pi)λW + piλV (1− 2/(rL))
]
· exp(rL)
· h(s− t)
=r2 · [1{b=0} + (ρ/L)1{b>0}] · exp(rt)[
1 + ρ(1− 2/(rL))
]
· exp(rL)
· h(s− t),
where ρ = (λV /λW )pi/(1− pi).
A.3 Derivation of Proposition 1
The following Lemma is useful to marginalize over T when the incubation period follows a
Gamma(α, β) distribution:
Lemma 3. For any r > 0 and b ≤ e ≤ s,∫ min(s,e)
b
exp(rt)hα,β(s− t) dt =
( β
β + r
)α
exp(rs)
[
Hα,β+r(s− b)−Hα,β+r((s− e)+)
]
.
Proof. By a change of variables,∫ min(s,e)
b
exp(rt)hα,β(s− t) dt
=
∫ min(s,e)
b
exp(rt)
βα
Γ(α)
(s− t)α−1 exp{−β(s− t)} dt
=
( β
β + r
)α
exp(rs)
∫ min(s,e)
b
(β + r)α
Γ(α)
(s− t)α−1 exp{−(β + r)(s− t)} dt
=
( β
β + r
)α
exp(rs)
[
Hα,β+r(s− b)−Hα,β+r((s− e)+)
]
.
The time of contraction T is not observed. Should it be observed, the full data unconditional
likelihood is given by
Luncond
(
ρ, r, h(·);T )
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=n∏
i=1
f(Bi, Ei, Ti, Si | (Bi, Ei, Ti, Si) ∈ D)
≈r2n ·
n∏
i=1
1{Bi=0} + (ρ/L)1{Bi>0}
1 + ρ(1− 2/(rL)) ·
n∏
i=1
1{Bi≤Ti≤min(Ei,Si)} · exp(r(Ti − L)) · h(Si − Ti)︸ ︷︷ ︸
A2,i
.
If we assume h(·) is the density of a Gamma distribution:
h(x) = hα,β(x) =
βα
Γ(α)
xα−1 exp(−βx) (x > 0),
then we can marginalize over Ti using Lemma 3:∫
A2,i dTi = exp
{
r(Si − L)
}( β
β + r
)α · [Hα,β+r(Si −Bi)−Hα,β+r((Si − Ei)+)],
In conclusion, the unconditional observed data likelihood is given by
Luncond(ρ, r, α, β) ≈ r2n
( β
β + r
)nα· n∏
i=1
{
1{Bi=0} + (ρ/L)1{Bi>0}
1 + ρ(1− 2/(rL))
× exp{r(Si − L)}[Hα,β+r(Si −Bi)−Hα,β+r((Si − Ei)+)]}.
The conditional observed data likelihood can be derived in the same way. Details are omitted.
A.4 Derivation of Proposition 2
By integrating the conditional density (17) over (b, e, s), the marginal distribution of T conditional
on (B,E, T, S) ∈ D is given by
fT (t | D, B = 0) ∝
∫ ∫ ∫
f(b, e, t, s | D) · 1{(b,e,t,s)∈D} · 1{b=0} db de ds
≈
∫ t
0
∫ L
t
∫ ∞
t
r2 · 1{b=0} · exp(rt)[
1 + ρ(1− 2/(rL))
]
· exp(rL)
· h(s− t) ds de db
∝
∫ L
t
∫ ∞
t
exp(rt)h(s− t) ds de
=
∫ L
t
exp(rt) de
= (L− t) exp(rt).
Assumption 2 says that the distribution of the symptom onset S only depends on the time of
transmission T (S ⊥ B,E | T ). Therefore the marginal distribution of S in exported Wuhan resident
cases is given by convolving the distribution of T with the distribution of the incubation period
S − T :
fS(s | D, B = 0) =
∫ min(L,s)
0
fT (t | D, B = 0)h(s− t) dt
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Under the parametric assumption that S − T follows a Gamma distribution (Assumption 4), we
have, for s ≥ L/2,
fS(s | D, B = 0) ∝∼
∫ min(L,s)
0
(L− t) exp(rt) · (s− t)α−1 exp{−β(s− t)} dt
= exp(rs) ·
∫ min(L,s)
0
[(L− s) + (s− t)](s− t)α−1 exp{−(β + r)(s− t)} dt
= exp(rs) ·
∫ s
(s−L)+
[(L− s)xα−1 + xα] exp{−(β + r)x} dx
= exp(rs) ·
{
(L− s) Γ(α)
(β + r)α
[
Hα,β+r(s)−Hα,β+r((s− L)+)
]
+
Γ(α+ 1)
(β + r)α+1
[
Hα+1,β+r(s)−Hα+1,β+r((s− L)+)
]}
∝ exp(rs) ·
{
(L− s)[Hα,β+r(s)−Hα,β+r((s− L)+)]
+
α
β + r
[
Hα+1,β+r(s)−Hα+1,β+r((s− L)+)
]}
.
≈ exp(rs) ·
{
(L− s)[1−Hα,β+r((s− L)+)] + α
β + r
[1−Hα+1,β+r((s− L)+)]
}
.
The last step uses the approximation that
1 ≈ Hα+1,β+r(L/2) ≤ Hα+1,β+r(s) ≤ Hα,β+r(s).
We next show that this is reasonable under the technical assumption L > 4(α + 5)/(β + r) in
Proposition 2. Suppose X ∼ Gamma(α+ 1, β + r). The Chernoff tail bound says that
1−Hα+1,β+r(L/2) = P(X > L/2) ≤ E[exp(cX)]
exp(cL/2)
=
(1− c/(β + r))−(α+1)
exp(cL/2)
for a < β + r.
By choosing c = (1− exp(−1))(β + r) ≈ 0.63(β + r), we have
1−Hα+1,β+r(L/2) ≤ exp(α+ 1)
exp{0.31(β + r)L} <
exp(α+ 1)
exp{0.31× 4(α+ 5)} < exp(1− 0.31× 20) < 0.01.
A.5 Derivation of Proposition 3
Let e− = min(e,M). Then under Assumptions 1 and 2, for (b, e, t, s) ∈ D and s ≤M ,
fT,S(t, s | b, e,D, S ≤M) = fT,S(t, s | b, e,D)∫ ∫
fT,S(t, s | b, e,D) ds dt
=
g(t)h(s− t)∫ e−
b g(t)
∫M
t h(s− t) ds dt
=
g(t)h(s− t)∫ e−
b g(t)H(M − t) dt
,
(27)
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where H(s) =
∫ s
0 h(x) dx is the distribution function of the incubation period. Assuming g(t) =
κ exp(rt) and using integration by parts, for r 6= 0,∫ e−
b
g(t)H(M − t) dt =κ
∫ e−
b
exp(rt)H(M − t) dt
=
κ
r
∫ e−
b
H(M − t) d exp(rt)
=
κ
r
[
exp(rt)H(M − t)
∣∣∣t=e−
t=b
+
∫ e−
b
exp(rt)h(M − t) dt
]
.
By using h(·) = hα,β(·) and using Lemma 3, we have∫ e−
b
g(t)Hα,β(M − t) dt = κ
r
[
exp(rt)Hα,β(M − t)−
( β
β + r
)α
exp(rM)Hα,β+r(M − t)
]∣∣∣∣t=e−
t=b
.
Now we integrate t in (27) from b to e− and get
fS(s | b, e,D, S ≤M)
=
r
(
β
β+r
)α
exp(rs)
[
Hα,β+r(s− b)−Hα,β+r((s− e)+)
]
[
exp(rt)Hα,β(M − t)−
(
β
β+r
)α
exp(rM)Hα,β+r(M − t)
]∣∣∣∣t=e−
t=b
.
For r = 0, using integration by parts,∫ e−
b
g(t)Hα,β(M − t) dt =κ
∫ M−b
(M−e)+
Hα,β(x) dx
=κ
[
xHα,β(x)
∣∣∣x=M−b
x=(M−e)+
−
∫ M−b
(M−e)+
xhα,β(x) dx
]
=κ
[
xHα,β(x)
∣∣∣x=M−b
x=(M−e)+
−
∫ M−b
(M−e)+
x · β
α
Γ(α)
xα−1 exp(−βx) dx
]
=κ
[
xHα,β(x)
∣∣∣x=M−b
x=(M−e)+
− α
β
∫ M−b
(M−e)+
βα+1
Γ(α+ 1)
xα exp(−βx) dx
]
=κ
[
xHα,β(x)− α
β
Hα+1,β(x)
]∣∣∣∣x=M−b
x=(M−e)+
.
We can similarly integrate t out and obtain the full data likelihood. Details are omitted.
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